REVIEW ARTICLE

Year : 2011  |  Volume : 1  |  Issue : 1  |  Page : 9-14

Toxoplasmosis - An update

Veena Mittal, RL Ichhpujani
Centre for AIDS and Related Diseases, National Center for Disease Control, New Delhi, India

Correspondence Address:
Veena Mittal
Additional Director and Head, Zoonosis Division, National Center for Disease Control, 22 Shamnath Marg, Delhi-110054
India

Source of Support: None, Conflict of Interest: None

Check

3

Read associated Retraction Notice: Retraction Notice with this article

DOI: 10.4103/2229-5070.72109

Abstract

Toxplasmosis is an important zoonotic disease caused by protozoan parasite Toxoplasma gondii. The disease affects one-third of the total world population. Transmission of the disease is mainly by ingestion of food or water contaminated with oocysts. Congenital toxoplasmosis occurs from the transplacental passage of the parasite from mother to fetus. In most adults it does not cause serious illness, but it can cause blindness and mental retardation in congenitally infected children, and it is a devastating disease in immunocompromised individuals. Diagnosis of toxoplasmosis can be established by the direct detection of the parasite or by serological methods. The most commonly used and effective therapeutic regimen is the combination of pyrimethamine with sulfadiazine and folinic acid. This article provides an overview and update on transmission, diagnosis, management, and prevention of toxoplasmosis.

Keywords: Toxoplama gondii, congential infection, oocysts

The article has been Retracted.

This article has been cited by 1 Treatments of Mycobacterium tuberculosis and Toxoplasma gondii with Selenium Nanoparticles Ikhazuagbe H. Ifijen, Best Atoe, Raphael O. Ekun, Augustine Ighodaro, Ifeanyi J. Odiachi BioNanoScience. 2023; [Pubmed] | [DOI] 2 Application of Dendrimers for Treating Parasitic Diseases Veronica Folliero,Carla Zannella,Annalisa Chianese,Debora Stelitano,Annalisa Ambrosino,Anna De Filippis,Marilena Galdiero,Gianluigi Franci,Massimiliano Galdiero Pharmaceutics. 2021; 13(3): 343 [Pubmed] | [DOI] 3 Toxoplasma gondii infection and pre-eclampsia among Sudanese women Shimos A Alshareef,Abubakr M Nasr,Ishag Adam Transactions of The Royal Society of Tropical Medicine and Hygiene. 2018; [Pubmed] | [DOI] 4 Analysis Concentration of <i>Toxoplasma gondii</i> on Anti-Toxoplasma IgG-IgM Antibody Levels, and the Outcomes of Pregnancy in Mice Balb/c Tigor Peniel Simanjuntak,Mochammad Hatta,Robert H. Sirait,Marni Br Karo,Lenny Irmawaty Sirait,Tetty Rina Aritonang,Syahrul Rauf,Ressy Dwiyanti Open Journal of Obstetrics and Gynecology. 2017; 07(03): 281 [Pubmed] | [DOI] 5 Assessment of self-produced PCR methods for the detection of Toxoplasma gondii DNA in meat Shoufu Jiang,Yanyan He,Yaoguang Zhang,Xiaoping Zhang,Li Jiang,Zhenyu Wang,Qian Zhu,Xiaojiang Ma Journal of Food Safety. 2016; [Pubmed] | [DOI] 6 Toxoplasma gondii seropositivity and risk factors in pregnant women followed up by the Family Health Strategy Rosiléia Marinho de Quadros,Gino Chaves da Rocha,Getúlio Romagna,Juliana Pellizzoni de Oliveira,Dadryhan Morghani Ribeiro,Sandra Márcia Tietz Marques Revista da Sociedade Brasileira de Medicina Tropical. 2015; 48(3): 338 [Pubmed] | [DOI] 7 Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV Apeksha Sahu,Satwant Kumar,Sreelakshmi K Sreenivasamurthy,Lakshmi Dhevi N Selvan,Anil K Madugundu,Soujanya D Yelamanchi,Vinuth N Puttamallesh,Gourav Dey,Abhijith K Anil,Anand Srinivasan,Kanchan K Mukherjee,Harsha Gowda,Parthasarathy Satishchandra,Anita Mahadevan,Akhilesh Pandey,Thottethodi Subrahmanya Prasad,Susarla Shankar Clinical Proteomics. 2014; 11(1): 39 [Pubmed] | [DOI]